Skip to main content
Erschienen in: Endocrine 2/2013

01.04.2013 | Meta-Analysis

Concordance of the late night salivary cortisol in patients with Cushing’s syndrome and elevated urine-free cortisol

verfasst von: Suhail A. R. Doi, Justin Clark, Anthony W. Russell

Erschienen in: Endocrine | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

The concordance of the late night salivary cortisol (LNSC) results with the 24-h urine-free cortisol (UFC) results in the biochemical screening for Cushing’s syndrome is unknown. We investigated this in a population of Cushing’s syndrome subjects. We used meta-analytic methods to pool proportions of LNSC-positive subjects from diagnostic evaluations of Cushing’s syndrome subjects where both tests were performed and the UFC was elevated (any level). Cushing’s syndrome was confirmed in all subjects by two out of three conventional tests. LNSC was collected between 22:00 to 24:00 h and measured around the same time period as the UFC. Minimum cutoffs of ≥4 and ≥10 nmol/L were used to determine concordance with the UFC and studies were limited to those that used radioimmunoassays or electrochemiluminiscence immunoassays for LNSC. The concordance of LNSC ≥4 nmol/L was 97 % (95 % CI 95–99 %) and studies were homogeneous. With LNSC ≥10 nmol/L, there was heterogeneity and two groups were discernible with a pooled concordance of 69 % (95 % CI 60–77 %) and 95 % (95 % CI 92–97 %). Within these sub-groups, studies were homogeneous and there was no difference between them in collection methods, assays used, geographic location, year of publication, or the quality of the underlying studies. The LNSC at a very specific cutoff detects at best 95 % of cases and at worst 69 % of cases of Cushing’s syndrome that are UFC positive. The two tests become equivalent at the more sensitive cutoff (>4 nmol/L). We conclude that, given its many benefits and the currently documented equivalence to the UFC, the LNSC should replace the conventional 24-h UFC as the frontline test when screening for Cushing’s syndrome.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat K.I. Alexandraki, A.B. Grossman, Is urinary free cortisol of value in the diagnosis of Cushing’s syndrome? Curr. Opin. Endocrinol. Diabetes Obes. 18, 259–263 (2011)PubMedCrossRef K.I. Alexandraki, A.B. Grossman, Is urinary free cortisol of value in the diagnosis of Cushing’s syndrome? Curr. Opin. Endocrinol. Diabetes Obes. 18, 259–263 (2011)PubMedCrossRef
2.
Zurück zum Zitat H. Raff, Salivary cortisol and the diagnosis of Cushing’s syndrome: a coming of age. Endocrine 41, 353–354 (2012)PubMedCrossRef H. Raff, Salivary cortisol and the diagnosis of Cushing’s syndrome: a coming of age. Endocrine 41, 353–354 (2012)PubMedCrossRef
3.
Zurück zum Zitat T. Carroll, H. Raff, J.W. Findling, Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocr. Pract. 15, 335–342 (2009)PubMedCrossRef T. Carroll, H. Raff, J.W. Findling, Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocr. Pract. 15, 335–342 (2009)PubMedCrossRef
4.
Zurück zum Zitat M.B. Elamin, M.H. Murad, R. Mullan, D. Erickson, K. Harris, S. Nadeem, R. Ennis, P.J. Erwin, V.M. Montori, Accuracy of diagnostic tests for Cushing’s syndrome: a systematic review and metaanalyses. J. Clin. Endocrinol. Metab. 93, 1553–1562 (2008)PubMedCrossRef M.B. Elamin, M.H. Murad, R. Mullan, D. Erickson, K. Harris, S. Nadeem, R. Ennis, P.J. Erwin, V.M. Montori, Accuracy of diagnostic tests for Cushing’s syndrome: a systematic review and metaanalyses. J. Clin. Endocrinol. Metab. 93, 1553–1562 (2008)PubMedCrossRef
5.
Zurück zum Zitat K.I. Alexandraki, A.B. Grossman, Novel insights in the diagnosis of Cushing’s syndrome. Neuroendocrinology 92(Suppl 1), 35–43 (2010)PubMedCrossRef K.I. Alexandraki, A.B. Grossman, Novel insights in the diagnosis of Cushing’s syndrome. Neuroendocrinology 92(Suppl 1), 35–43 (2010)PubMedCrossRef
6.
Zurück zum Zitat B.A. Jonsson, B. Malmberg, A. Amilon, A. Helene Garde, P. Orbaek, Determination of cortisol in human saliva using liquid chromatography–electrospray tandem mass spectrometry. J. Chromatogr. B. 784, 63–68 (2003)CrossRef B.A. Jonsson, B. Malmberg, A. Amilon, A. Helene Garde, P. Orbaek, Determination of cortisol in human saliva using liquid chromatography–electrospray tandem mass spectrometry. J. Chromatogr. B. 784, 63–68 (2003)CrossRef
7.
Zurück zum Zitat W.J. Inder, G. Dimeski, A. Russell, Measurement of salivary cortisol in 2012-laboratory techniques and clinical indications. Clin. Endocrinol. (Oxf.) 77(5), 645–651 (2012)CrossRef W.J. Inder, G. Dimeski, A. Russell, Measurement of salivary cortisol in 2012-laboratory techniques and clinical indications. Clin. Endocrinol. (Oxf.) 77(5), 645–651 (2012)CrossRef
8.
Zurück zum Zitat A. Leon-Justel, M.A. Mangas, R. Infante Fontan, J. Castro Luque, E. Venegas Moreno, A. Madrazo Atutxa, T. Herrera del Rey, J.F. Martin-Rodriguez, A. Soto-Moreno, A. Leal-Cerro, Budget impact of using midnight salivary cortisol in the diagnosis of hypercortisolism. Clin. Chim. Acta 412, 2248–2253 (2011)PubMedCrossRef A. Leon-Justel, M.A. Mangas, R. Infante Fontan, J. Castro Luque, E. Venegas Moreno, A. Madrazo Atutxa, T. Herrera del Rey, J.F. Martin-Rodriguez, A. Soto-Moreno, A. Leal-Cerro, Budget impact of using midnight salivary cortisol in the diagnosis of hypercortisolism. Clin. Chim. Acta 412, 2248–2253 (2011)PubMedCrossRef
9.
Zurück zum Zitat C.A. Carrasco, M. Garcia, M. Goycoolea, J. Cerda, J. Bertherat, O. Padilla, D. Meza, N. Wohllk, T. Quiroga, Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing’s syndrome using an automated immunoassay system. Endocrine 41, 487–493 (2012)PubMedCrossRef C.A. Carrasco, M. Garcia, M. Goycoolea, J. Cerda, J. Bertherat, O. Padilla, D. Meza, N. Wohllk, T. Quiroga, Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing’s syndrome using an automated immunoassay system. Endocrine 41, 487–493 (2012)PubMedCrossRef
10.
Zurück zum Zitat C. Carrozza, S.M. Corsello, R.M. Paragliola, F. Ingraudo, S. Palumbo, P. Locantore, A. Sferrazza, A. Pontecorvi, C. Zuppi, Clinical accuracy of midnight salivary cortisol measured by automated electrochemiluminescence immunoassay method in Cushing’s syndrome. Ann. Clin. Biochem. 47, 228–232 (2010)PubMedCrossRef C. Carrozza, S.M. Corsello, R.M. Paragliola, F. Ingraudo, S. Palumbo, P. Locantore, A. Sferrazza, A. Pontecorvi, C. Zuppi, Clinical accuracy of midnight salivary cortisol measured by automated electrochemiluminescence immunoassay method in Cushing’s syndrome. Ann. Clin. Biochem. 47, 228–232 (2010)PubMedCrossRef
11.
Zurück zum Zitat E.M. Cardoso, A.L. Arregger, O.R. Tumilasci, L.N. Contreras, Diagnostic value of salivary cortisol in Cushing’s syndrome (CS). Clin. Endocrinol. (Oxf.) 70, 516–521 (2009)CrossRef E.M. Cardoso, A.L. Arregger, O.R. Tumilasci, L.N. Contreras, Diagnostic value of salivary cortisol in Cushing’s syndrome (CS). Clin. Endocrinol. (Oxf.) 70, 516–521 (2009)CrossRef
12.
Zurück zum Zitat P.F. Whiting, M.E. Weswood, A.W. Rutjes, J.B. Reitsma, P.N. Bossuyt, J. Kleijnen, Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med. Res. Methodol. 6, 9 (2006)PubMedCrossRef P.F. Whiting, M.E. Weswood, A.W. Rutjes, J.B. Reitsma, P.N. Bossuyt, J. Kleijnen, Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med. Res. Methodol. 6, 9 (2006)PubMedCrossRef
13.
Zurück zum Zitat B. Takkouche, C. Cadarso-Suarez, D. Spiegelman, Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am. J. Epidemiol. 150, 206–215 (1999)PubMedCrossRef B. Takkouche, C. Cadarso-Suarez, D. Spiegelman, Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am. J. Epidemiol. 150, 206–215 (1999)PubMedCrossRef
15.
Zurück zum Zitat S.A. Doi, J.J. Barendregt, E.L. Mozurkewich, Meta-analysis of heterogenous clinical trials: an empirical example. Contemp. Clin. Trials 32, 288–298 (2011)PubMedCrossRef S.A. Doi, J.J. Barendregt, E.L. Mozurkewich, Meta-analysis of heterogenous clinical trials: an empirical example. Contemp. Clin. Trials 32, 288–298 (2011)PubMedCrossRef
16.
Zurück zum Zitat H. Raff, J.L. Raff, J.W. Findling, Late-night salivary cortisol as a screening test for Cushing’s syndrome. J. Clin. Endocrinol. Metab. 83, 2681–2686 (1998)PubMedCrossRef H. Raff, J.L. Raff, J.W. Findling, Late-night salivary cortisol as a screening test for Cushing’s syndrome. J. Clin. Endocrinol. Metab. 83, 2681–2686 (1998)PubMedCrossRef
17.
Zurück zum Zitat R.I. Gafni, D.A. Papanicolaou, L.K. Nieman, Nighttime salivary cortisol measurement as a simple, noninvasive, outpatient screening test for Cushing’s syndrome in children and adolescents. J. Pediatr. 137, 30–35 (2000)PubMedCrossRef R.I. Gafni, D.A. Papanicolaou, L.K. Nieman, Nighttime salivary cortisol measurement as a simple, noninvasive, outpatient screening test for Cushing’s syndrome in children and adolescents. J. Pediatr. 137, 30–35 (2000)PubMedCrossRef
18.
Zurück zum Zitat D.A. Papanicolaou, N. Mullen, I. Kyrou, L.K. Nieman, Nighttime salivary cortisol: a useful test for the diagnosis of Cushing’s syndrome. J. Clin. Endocrinol. Metab. 87, 4515–4521 (2002)PubMedCrossRef D.A. Papanicolaou, N. Mullen, I. Kyrou, L.K. Nieman, Nighttime salivary cortisol: a useful test for the diagnosis of Cushing’s syndrome. J. Clin. Endocrinol. Metab. 87, 4515–4521 (2002)PubMedCrossRef
19.
Zurück zum Zitat P. Putignano, P. Toja, A. Dubini, F. Pecori Giraldi, S.M. Corsello, F. Cavagnini, Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing’s syndrome. J. Clin. Endocrinol. Metab. 88, 4153–4157 (2003)PubMedCrossRef P. Putignano, P. Toja, A. Dubini, F. Pecori Giraldi, S.M. Corsello, F. Cavagnini, Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing’s syndrome. J. Clin. Endocrinol. Metab. 88, 4153–4157 (2003)PubMedCrossRef
20.
Zurück zum Zitat M. Yaneva, H. Mosnier-Pudar, M.A. Dugue, S. Grabar, Y. Fulla, X. Bertagna, Midnight salivary cortisol for the initial diagnosis of Cushing’s syndrome of various causes. J. Clin. Endocrinol. Metab. 89, 3345–3351 (2004)PubMedCrossRef M. Yaneva, H. Mosnier-Pudar, M.A. Dugue, S. Grabar, Y. Fulla, X. Bertagna, Midnight salivary cortisol for the initial diagnosis of Cushing’s syndrome of various causes. J. Clin. Endocrinol. Metab. 89, 3345–3351 (2004)PubMedCrossRef
21.
Zurück zum Zitat A. Viardot, P. Huber, J.J. Puder, H. Zulewski, U. Keller, B. Muller, Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. J. Clin. Endocrinol. Metab. 90, 5730–5736 (2005)PubMedCrossRef A. Viardot, P. Huber, J.J. Puder, H. Zulewski, U. Keller, B. Muller, Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. J. Clin. Endocrinol. Metab. 90, 5730–5736 (2005)PubMedCrossRef
22.
Zurück zum Zitat C.A. Carrasco, J. Coste, L. Guignat, L. Groussin, M.A. Dugue, S. Gaillard, X. Bertagna, J. Bertherat, Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing’s disease. J. Clin. Endocrinol. Metab. 93, 4728–4734 (2008)PubMedCrossRef C.A. Carrasco, J. Coste, L. Guignat, L. Groussin, M.A. Dugue, S. Gaillard, X. Bertagna, J. Bertherat, Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing’s disease. J. Clin. Endocrinol. Metab. 93, 4728–4734 (2008)PubMedCrossRef
23.
Zurück zum Zitat M.L. Nunes, S. Vattaut, J.B. Corcuff, A. Rault, H. Loiseau, B. Gatta, N. Valli, L. Letenneur, A. Tabarin, Late-night salivary cortisol for diagnosis of overt and subclinical Cushing’s syndrome in hospitalized and ambulatory patients. J. Clin. Endocrinol. Metab. 94, 456–462 (2009)PubMedCrossRef M.L. Nunes, S. Vattaut, J.B. Corcuff, A. Rault, H. Loiseau, B. Gatta, N. Valli, L. Letenneur, A. Tabarin, Late-night salivary cortisol for diagnosis of overt and subclinical Cushing’s syndrome in hospitalized and ambulatory patients. J. Clin. Endocrinol. Metab. 94, 456–462 (2009)PubMedCrossRef
24.
Zurück zum Zitat L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93, 1526–1540 (2008)PubMedCrossRef L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93, 1526–1540 (2008)PubMedCrossRef
25.
Zurück zum Zitat J. Newell-Price, X. Bertagna, A.B. Grossman, L.K. Nieman, Cushing’s syndrome. Lancet 367, 1605–1617 (2006)PubMedCrossRef J. Newell-Price, X. Bertagna, A.B. Grossman, L.K. Nieman, Cushing’s syndrome. Lancet 367, 1605–1617 (2006)PubMedCrossRef
26.
Zurück zum Zitat G. Beko, I. Varga, E. Glaz, M. Sereg, K. Feldman, M. Toth, K. Racz, A. Patocs, Cutoff values of midnight salivary cortisol for the diagnosis of overt hypercortisolism are highly influenced by methods. Clin. Chim. Acta 411, 364–367 (2010)PubMedCrossRef G. Beko, I. Varga, E. Glaz, M. Sereg, K. Feldman, M. Toth, K. Racz, A. Patocs, Cutoff values of midnight salivary cortisol for the diagnosis of overt hypercortisolism are highly influenced by methods. Clin. Chim. Acta 411, 364–367 (2010)PubMedCrossRef
27.
Zurück zum Zitat Z.E. Belaya, A.V. Iljin, G.A. Melnichenko, L.Y. Rozhinskaya, N.V. Dragunova, L.K. Dzeranova, S.A. Butrova, E.A. Troshina, I.I. Dedov, Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing’s syndrome. Endocrine 41, 494–500 (2012)PubMedCrossRef Z.E. Belaya, A.V. Iljin, G.A. Melnichenko, L.Y. Rozhinskaya, N.V. Dragunova, L.K. Dzeranova, S.A. Butrova, E.A. Troshina, I.I. Dedov, Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing’s syndrome. Endocrine 41, 494–500 (2012)PubMedCrossRef
28.
Zurück zum Zitat C. Jung, J.T. Ho, D.J. Torpy, A. Rogers, M. Doogue, J.G. Lewis, R.J. Czajko, W.J. Inder, A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J. Clin. Endocrinol. Metab. 96, 1533–1540 (2011)PubMedCrossRef C. Jung, J.T. Ho, D.J. Torpy, A. Rogers, M. Doogue, J.G. Lewis, R.J. Czajko, W.J. Inder, A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J. Clin. Endocrinol. Metab. 96, 1533–1540 (2011)PubMedCrossRef
29.
Zurück zum Zitat D.A. Vassiliadi, S. Tsagarakis, Subclinical hypercortisolism: debatable or visible on the lightbox? Endocrine 42, 7–8 (2012)PubMedCrossRef D.A. Vassiliadi, S. Tsagarakis, Subclinical hypercortisolism: debatable or visible on the lightbox? Endocrine 42, 7–8 (2012)PubMedCrossRef
30.
Zurück zum Zitat S. Tsagarakis, D. Vassiliadi, N. Thalassinos, Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications. J. Endocrinol. Invest. 29, 471–482 (2006)PubMed S. Tsagarakis, D. Vassiliadi, N. Thalassinos, Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications. J. Endocrinol. Invest. 29, 471–482 (2006)PubMed
31.
Zurück zum Zitat S. Kidambi, H. Raff, J.W. Findling, Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing’s syndrome. Eur. J. Endocrinol. 157, 725–731 (2007)PubMedCrossRef S. Kidambi, H. Raff, J.W. Findling, Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing’s syndrome. Eur. J. Endocrinol. 157, 725–731 (2007)PubMedCrossRef
Metadaten
Titel
Concordance of the late night salivary cortisol in patients with Cushing’s syndrome and elevated urine-free cortisol
verfasst von
Suhail A. R. Doi
Justin Clark
Anthony W. Russell
Publikationsdatum
01.04.2013
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2013
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9855-0

Weitere Artikel der Ausgabe 2/2013

Endocrine 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.